☆ 4.7 Article

Bevacizumab Improves Pathological Response of Colorectal Cancer Liver Metastases Treated with XELOX/FOLFOX

ANNALS OF SURGICAL ONCOLOGY (2010)

期刊

ANNALS OF SURGICAL ONCOLOGY

卷 17, 期 8, 页码 2059-2065

出版社

SPRINGER

DOI: 10.1245/s10434-010-0972-9

关键词

-

类别

Oncology Surgery

资金

Hoffmann-LaRoche Ltd.
Sanofi-Aventis

向作者/读者索取更多资源

Protocol

Reagent

摘要

Histological response of colorectal cancer liver metastases to chemotherapy may be graded based on the extent of tumor regression. The knowledge about the effect of bevacizumab, if given in addition to fluoropyrimidines and oxaliplatin, on tumor regression and its consequences on clinical outcome is limited. Resected liver metastases from patients of 2 prospective nonrandomized trials (fluoropyrimidines and oxaliplatin +/- A bevacizumab) were analyzed retrospectively. Histological response was analyzed according to an established tumor regression grading for colorectal cancer liver metastases. Tumor regression grades (TRGs) were correlated to progression-free and overall survival. Bevacizumab improved tumor regression to chemotherapy significantly. Improvement in histological response was translated into a significant prolongation of progression-free and overall survival. Classifying histological response based on tumor regression grades qualifies to predict the outcome of patients with colorectal cancer liver metastases. Tumor regression grading provides a standardized pathological response evaluation, against which radiologic response on chemotherapy including biologicals can be prospectively evaluated.

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Radiology, Nuclear Medicine & Medical Imaging

Identifying response in colorectal liver metastases treated with bevacizumab: development of RECIST by combining contrast-enhanced and diffusion-weighted MRI

Li-Heng Liu, Guo-Feng Zhou, Han Lv, Zhen-Chang Wang, Sheng-Xiang Rao, Meng-Su Zeng

Summary: Combining functional and size-based MRI criteria to develop D-RECIST could better predict survival outcomes in patients with colorectal liver metastases treated with bevacizumab, compared to traditional RECIST criteria.

EUROPEAN RADIOLOGY (2021)

添加到收藏夹

Article Immunology

Case Report: Marked Survival Advantage of Two Colorectal Cancer Patients with Liver Metastases Treated with Vigil and FOLFOX-6

Vedin Barve, Ned Adams, Laura Stanbery, Luisa Manning, Staci Horvath, Gladice Wallraven, Ernest Bognar, Minal Barve, John Nemunaitis

Summary: Colorectal cancer is the third most diagnosed cancer in the US with low survival rates and liver metastasis being a common occurrence. Vigil, an immunotherapy, combined with FOLFOX-6 chemotherapy showed remarkable results in two patients, with no disease recurrence after over eight years. Both patients also exhibited systemic immune response to Vigil therapy.

VACCINES (2021)

添加到收藏夹

Article Oncology

Pathological Evaluation of Resected Colorectal Liver Metastases: mFOLFOX6 Plus Bevacizumab versus mFOLFOX6 Plus Cetuximab in the Phase II ATOM Trial

Takao Takahashi, Kazuyuki Ishida, Yasunori Emi, Michiie Sakamoto, Johji Imura, Shinichi Aishima, Kei Muro, Hiroyuki Uetake, Eiji Oki, Yu Katayose, Kazuhiro Yoshida, Michiaki Unno, Ichinosuke Hyodo, Naohiro Tomita, Kenichi Sugihara, Yoshihiko Maehara

Summary: This study compared the histopathological responses of liver-limited colorectal metastases in patients who received different chemotherapy regimens and found differences between bevacizumab and cetuximab in terms of histological response. The study also showed that tumor regression grade (TRG) and dangerous halo (DH) are associated with prognosis.

CANCERS (2022)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Rim enhancement on hepatobiliary phase of pre-treatment 3.0 T MRI: A potential marker for early chemotherapy response in colorectal liver metastases treated with XELOX

Xinxin Wang, Yu Wang, Ziqian Zhang, Meng Zhou, Xueyan Zhou, Hongxin Zhao, Jiqing Xing, Yang Zhou

Summary: The study found that the CE patterns and SI ratio parameters on the hepatobiliary phase are useful indicators for evaluating therapeutic response in patients with colorectal liver metastases. Rim enhancement was more frequent in the responding group, and parameters such as diameter, CE patterns, and SI ratios had significant associations with chemotherapy response.

EUROPEAN JOURNAL OF RADIOLOGY (2021)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Radiomics diagnosed histopathological growth pattern in prediction of response and 1-year progression free survival for colorectal liver metastases patients treated with bevacizumab containing chemotherapy

Shengcai Wei, Yuqi Han, Hanjiang Zeng, Shuai Ye, Jin Cheng, Fan Chai, Jingwei Wei, Jianwei Zhang, Nan Hong, Yudi Bao, Jing Zhou, Yingjiang Ye, Xiaochun Meng, Yuwen Zhou, Yanhong Deng, Meng Qiu, Jie Tian, Yi Wang

Summary: This study investigated a radiomics model for predicting the prognosis of patients with colorectal liver metastases treated with bevacizumab-containing chemotherapy. The results showed that the HGP diagnosed using this model can be an effective predictor of patient survival, with the D pattern indicating a significantly longer progression-free survival compared to the R pattern or mixed patterns.

EUROPEAN JOURNAL OF RADIOLOGY (2021)

添加到收藏夹

Article Oncology

Pathological complete response to immune checkpoint inhibitor in patients with colorectal cancer liver metastases harboring POLE exonuclease domain mutation

Lei Wen, Zhigang Chen, Xiaomeng Ji, William Pat Fong, Qiong Shao, Chao Ren, Yanyu Cai, Binkui Li, Yunfei Yuan, Deshen Wang, Yuhong Li

Summary: CRLM patients with POLE EDM exhibit distinct clinical characteristics and extremely high TMB, and show significant clinical response to ICI-based combination therapy. Complete sequencing of POLE exonuclease domains is recommended in CRLM patients clinically.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

添加到收藏夹

Article Oncology

Intersurgeon Variability in Local Treatment Planning for Patients with Initially Unresectable Colorectal Cancer Liver Metastases: Analysis of the Liver Expert Panel of the Dutch Colorectal Cancer Group

Marinde J. G. Bond, Babette I. Kuiper, Karen Bolhuis, Aysun Komurcu, Martinus J. van Amerongen, Thiery Chapelle, Cornelis H. C. Dejong, Marc R. W. Engelbrecht, Michael F. Gerhards, Dirk J. Grunhagen, Thomas van Gulik, John J. Hermans, Koert P. de Jong, Joost M. Klaase, Niels F. M. Kok, Wouter K. G. Leclercq, Mike S. L. Liem, Krijn P. van Lienden, I. Quintus Molenaar, Ulf P. Neumann, Gijs A. Patijn, Arjen M. Rijken, Theo M. Ruers, Cornelis Verhoef, Johannes H. W. de Wilt, Geert Kazemier, Anne M. May, Cornelis J. A. Punt, Rutger-Jan Swijnenburg

Summary: This study evaluated the variability in assessing resectability and local treatment planning for patients with initially unresectable colorectal cancer liver metastases. The results showed differences and disagreements in the evaluations, highlighting the need for consensus guidelines to prevent unwarranted variability in clinical practice.

ANNALS OF SURGICAL ONCOLOGY (2023)

添加到收藏夹

Article Oncology

Outcomes of Mixed Pathologic Response in Patients with Multiple Colorectal Liver Metastases Treated with Neoadjuvant Chemotherapy and Liver Resection

Meredith C. Mason, Maciej Krasnodebski, Caitlin A. Hester, Anai N. Kothari, Caeli Barker, Yujiro Nishioka, Yi-Ju Chiang, Timothy E. Newhook, Ching-Wei D. Tzeng, Yun Shin Chun, Jean-Nicolas Vauthey, Hop S. Tran Cao

Summary: In patients with colorectal liver metastases, mixed pathologic response is possible in multiple metastases. Patients with mixed response have higher survival rates compared to other pathologic responses, suggesting that the greatest response achieved in any metastasis is the best predictor of survival.

ANNALS OF SURGICAL ONCOLOGY (2022)

添加到收藏夹

Article Oncology

FOLFIRI plus BEvacizumab or aFLIbercept after FOLFOX-bevacizumab failure for COlorectal cancer (BEFLICO): An AGEO multicenter study

Cecile Torregrosa, Simon Pernot, Pauline Vaflard, Audrey Perret, Christophe Tournigand, Violaine Randrian, Solene Doat, Cindy Neuzillet, Valerie Moulin, Morgane Stouvenot, Gael Roth, Tiffany Darbas, Benjamin Auberger, Tiphaine Godet, Marion Jaffrelot, Aurelien Lambert, Olivier Dubreuil, Cassandre Gluszak, Alice Bernard-Tessier, Anthony Turpin, Lola-Jade Palmieri, Olivier Bouche, Gael Goujon, Thierry Lecomte, David Sefrioui, Christophe Locher, Lucien Grados, Pauline Gignoux, Stephanie Trager, Elise Nassif, Angelique Saint, Pascal Hammel, Cedric Lecaille, Mathilde Bureau, Marine Perrier, Damien Botsen, Vincent Bourgeois, Julien Taieb, Edouard Auclin

Summary: In second-line treatment, for patients with metastatic colorectal cancer, the combination of FOLFIRI and bevacizumab is associated with longer overall survival and progression-free survival compared to the combination of FOLFIRI and aflibercept.

INTERNATIONAL JOURNAL OF CANCER (2022)

添加到收藏夹

Article Oncology

A Randomized, Open-Label, Multicenter, Phase 3 Study of High-Dose Vitamin C Plus FOLFOX ? Bevacizumab versus FOLFOX ? Bevacizumab in Unresectable Untreated Metastatic Colorectal Cancer (VITALITY Study)

Feng Wang, Ming -Ming He, Jian Xiao, Yan-Qiao Zhang, Xiang-Lin Yuan, Wei-Jia Fang, Yan Zhang, Wei Wang, Xiao-Hua Hu, Zhi-Gang Ma, Yi-Chen Yao, Zhi-Xiang Zhuang, Fu-Xiang Zhou, Jie-Er Ying, Ying Yuan, Qing-Feng Zou, Zeng-Qing Guo, Xiang-Yuan Wu, Ying Jin, Zong-Jiong Mai, Zhi-Qiang Wang, Hong Qiu, Ying Guo, Si -Mei Shi, Shuang-Zhen Chen, Hui-Yan Luo, Dong-Sheng Zhang, Feng-Hua Wang, Yu-Hong Li, Rui-Hua Xu

Summary: High-dose vitamin C plus chemotherapy did not show superior progression-free survival compared to chemotherapy alone in patients with metastatic colorectal cancer as first-line treatment, but may be beneficial in patients with mCRC harboring RAS mutation.

CLINICAL CANCER RESEARCH (2022)

添加到收藏夹

Article Oncology

Comparison of Neoadjuvant Systemic Chemotherapy Protocols for the Curative-Intent Management of Peritoneal Metastases from Colorectal Cancer, Regarding Morphological Response, Pathological Response, and Long-Term Outcomes: A Retrospective Study

Florian Fanget, Amaniel Kefleyesus, Julien Peron, Isabelle Bonnefoy, Laurent Villeneuve, Guillaume Passot, Pascal Rousset, Benoit You, Nazim Benzerdjeb, Olivier Glehen, Vahan Kepenekian

Summary: In this retrospective study, a FOLFIRINOX regimen as NACT seemed to result in better long-term outcomes for CRPM patients after complete CRS/HIPEC, although with higher morbidity.

ANNALS OF SURGICAL ONCOLOGY (2023)

添加到收藏夹

Article Oncology

FOLFOX plus panitumumab or FOLFOX alone as additive therapy following R0/1 resection of RAS wild-type colorectal cancer liver metastases - The PARLIM trial (AIO KRK 0314)

Dominik Paul Modest, Meinolf Karthaus, Stefan Kasper, Nicolas Moosmann, Verena Keitel, Alexander Kiani, Jens Uhlig, Lutz Jacobasch, Ludwig Fischer Weikersthal, Martin Fuchs, Florian Kaiser, Christian Lerchenmueller, Dagmar Sent, Christian Junghanss, Swantje Held, Sylvie Lorenzen, Klaus Kaczirek, Andreas Jung, Sebastian Stintzing, Volker Heinemann

Summary: The trial investigated the addition of panitumumab to chemotherapy in RAS wild-type colorectal cancer patients. While the experimental arm showed trends towards improved survival, the primary endpoint of progression-free survival was not met.

EUROPEAN JOURNAL OF CANCER (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Colorectal Cancer, Liver Metastases and Biotherapies

Daniel-Clement Osei-Bordom, Sivesh Kamarajah, Niki Christou

Summary: In the clinical management of liver metastasis of colorectal cancer, surgeons and oncologists categorize the metastasis into resectable and non-resectable groups to initiate tailored therapeutics. The combination of targeted therapies and biotherapies around these two entities is being actively explored to determine the ideal conditions for their application to improve patient survival and quality of life.

BIOMEDICINES (2021)

添加到收藏夹

Article Oncology

Prognosis of resectable colorectal liver metastases after surgery associated with pathological features of primary tumor

Dawei Chen, Qingshan Li, Haibo Yu

Summary: This study aimed to investigate the expression levels and prognostic roles of MMR, Ki67, and LVI in colorectal liver metastases (CRLM). The study found that MMR, Ki67, and LVI were significantly correlated with prognosis. Multivariate analysis showed that higher serum CA199 levels, N1-2 stage, the presence of LVI, higher Ki67, and pMMR all predicted worse overall survival (OS) and disease-free survival (DFS) in CRLM patients. A nomogram model was constructed to predict the OS of these patients after liver metastasis surgery.

FRONTIERS IN ONCOLOGY (2023)

添加到收藏夹

Article Surgery

Survival Outcomes After Portal Vein Embolization and Liver Resection Compared With Liver Transplant for Patients With Extensive Colorectal Cancer Liver Metastases

Svein Dueland, Sheraz Yaqub, Trygve Syversveen, Ulrik Carling, Morten Hagness, Kristoffer W. Brudvik, Pal-Dag Line

Summary: The study compared the overall survival rates of patients with colorectal cancer and high liver metastasis tumor load who received liver transplant or PVE and liver resection, with patients who received liver transplant showing higher survival rates than those who underwent PVE and liver resection.

JAMA SURGERY (2021)

添加到收藏夹

Article Critical Care Medicine

Gender has no influence on mortality after burn injuries: A 20-year single center study with 839 patients

Ines A. Ederer, Stefan Hacker, Nikolaus Sternat, Anna Waldmann, Olivia Salameh, Christine Radtke, Reinhard Pauzenberger

BURNS (2019)

添加到收藏夹

Article Anesthesiology

Effect of Intraoperative Goal-directed Balanced Crystalloid versus Colloid Administration on Major Postoperative Morbidity A Randomized Trial

Barbara Kabon, Daniel I. Sessler, Andrea Kurz

ANESTHESIOLOGY (2019)

添加到收藏夹

Article Surgery

Bony Fixation of the Nasal Framework

Sebastian Haack, Stefan Hacker, Steven Mann, Wolfgang Gubisch

FACIAL PLASTIC SURGERY (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

Predicting Postoperative Liver Dysfunction Based on Blood-Derived MicroRNA Signatures

Patrick Starlinger, Hubert Hackl, David Pereyra, Susanna Skalicky, Elisabeth Geiger, Michaela Finsterbusch, Dietmar Tamandl, Christine Brostjan, Thomas Gruenberger, Matthias Hackl, Alice Assinger

HEPATOLOGY (2019)

添加到收藏夹

Article Medicine, General & Internal

Sexual dimorphism in the anatomy of the ulnar collateral thumb ligament

Martin F. Vierhapper, Gabriela K. Muschitz, Stefan Hacker, Sandra E. Boesmueller, Michael Pretterklieber, Hugo B. Kitzinger

WIENER KLINISCHE WOCHENSCHRIFT (2019)

添加到收藏夹

Article Dermatology

Does obesity impact the outcome of severely burned patients?

Reinhard Pauzenberger, Christine Radtke, Ines A. Ederer, Stefan Hacker, Anna Waldmann, Nikolaus Sternat, Isabella Franke, Alexander Thury, Lucie Harpain, Simona Stievano

INTERNATIONAL WOUND JOURNAL (2020)

添加到收藏夹

Article Surgery

40 Years of Total Extracorporeal Septal Reconstruction: The Past, Present, and Future

Wolfgang Gubisch, Stefan Hacker, Jens Neumann, Sebastian Haack

PLASTIC AND RECONSTRUCTIVE SURGERY (2020)

添加到收藏夹

Article Oncology

The Immune Phenotype of Isolated Lymphoid Structures in Non-Tumorous Colon Mucosa Encrypts the Information on Pathobiology of Metastatic Colorectal Cancer

Felicitas Mungenast, Anastasia Meshcheryakova, Andrea Beer, Martina Salzmann, Dietmar Tamandl, Thomas Gruenberger, Peter Pietschmann, Oskar Koperek, Peter Birner, Ilan Kirsch, Harlan Robins, Martina Mittlboeck, Markus Jaritz, Michael Bergmann, Philip Zimmermann, Diana Mechtcheriakova

CANCERS (2020)

添加到收藏夹

Article Biotechnology & Applied Microbiology

The secretome of stressed peripheral blood mononuclear cells increases tissue survival in a rodent epigastric flap model

Stefan Hacker, Rainer Mittermayr, Denise Traxler, Claudia Keibl, Annika Resch, Stefan Salminger, Harald Leiss, Philipp Hacker, Christian Gabriel, Bahar Golabi, Reinhard Pauzenberger, Paul Slezak, Maria Laggner, Michael Mildner, Wolfgang Michlits, Hendrik J. Ankersmit

Summary: The study investigated the beneficial effects of a secretome derived from gamma-irradiated PBMCs on tissue survival, angiogenesis, and clinical parameters after flap surgery in a rodent epigastric flap model. Significant reductions in tissue necrosis rate and increased vessel counts were observed with PBMCsec treatment, suggesting its potential as a therapeutic approach in reconstructive surgery. Seroma formation was also decreased after treatment with fibrin sealant with or without the addition of PBMCsec, indicating improved outcomes post-surgery.

BIOENGINEERING & TRANSLATIONAL MEDICINE (2021)

添加到收藏夹

Letter Surgery

Letter to the Editor: Controllable Factors to Reduce the Rate of Complications in Primary Breast Augmentation: A Review of the Literature

Helena S. Leitner, Nina Schimek, Ines Ederer, Stefan Hacker, Reinhard Pauzenberger

AESTHETIC PLASTIC SURGERY (2022)

添加到收藏夹

Editorial Material Surgery

Invited Discussion on: Management of Patients Seeking Surgical Rhinoplasty with Previous Nasal Injections of Hyaluronic Acid

Wolfgang Gubisch, Stefan Hacker

AESTHETIC PLASTIC SURGERY (2021)

添加到收藏夹

Article Medicine, General & Internal

Effect of Goal-Directed Crystalloid versus Colloid Administration on Perioperative Hemostasis in Partial Hepatectomy: A Randomized, Controlled Trial

Johannes Gratz, Oliver Zotti, Andre Pausch, Marion Wiegele, Edith Fleischmann, Thomas Gruenberger, Claus G. Krenn, Barbara Kabon

Summary: In this study, the goal-directed use of hydroxyethyl starch was found to impair fibrin polymerization when compared with lactated Ringer's solution, but the effects were transient and normalized within 24 hours postoperatively. There were no significant differences in plasma fibrinogen levels or blood loss between the two groups.

JOURNAL OF CLINICAL MEDICINE (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Discrimination between 34 of 36 Possible Combinations of Three C>T SNP Genotypes in the MGMT Promoter by High Resolution Melting Analysis Coupled with Pyrosequencing Using A Single Primer Set

Katja Zappe, Christine Pirker, Heidi Miedl, Martin Schreiber, Petra Heffeter, Georg Pfeiler, Stefan Hacker, Werner Haslik, Sabine Spiegl-Kreinecker, Margit Cichna-Markl

Summary: The study combined HRM analysis with PSQ to improve the discrimination power for genotyping SNPs, successfully applied to stable cell lines and tumor cell lines, demonstrating potential applications in the field of genotyping.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

添加到收藏夹

Article Medicine, General & Internal

BMI Specific Complications Following Implant-Based Breast Reconstruction after Mastectomy

Helena Sophie Leitner, Reinhard Pauzenberger, Ines Ana Ederer, Christine Radtke, Stefan Hacker

Summary: "The impact of BMI on postoperative complications following implant-based breast reconstruction varies, with longer operative times significantly increasing the risk of complications."

JOURNAL OF CLINICAL MEDICINE (2021)

添加到收藏夹

Article Oncology

The Effect of Induction Chemotherapy with VEGF Inhibition on Tumor Response in Synchronously Metastasized Potentially Resectable Colorectal Cancer

Rebecca Thonhauser, Marcus Poglitsch, Jan Philipp Jonas, Yawen Dong, Madita Tschoegl, Mariel Gramberger, Mohamed Salem, Jonas Santol, Irmgard Brandl, Martin Klimpfinger, Constantin Vierziger, Thomas Gruenberger

Summary: This study compared the use of VEGF and EGFR antibodies in the treatment of synchronous metastasized colorectal cancer patients. The results showed that patients treated with VEGF antibodies had a better pathological response of the primary tumor and longer recurrence-free survival compared to those treated with EGFR antibodies. There was no difference in overall survival.

CANCERS (2023)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.